Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The Company’s intellectual property portfolio, which includes additional pending patents, covers a broad formulation platform of a unique suspension comprising aqueous, amorphous nanodispersions of cyclosporine.
Lead Product(s): Cyclosporine
Therapeutic Area: Ophthalmology Product Name: Cyclosporine-Generic
Highest Development Status: IND EnablingProduct Type: Peptide
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 20, 2022